Pharmacovigilance & Pharmacoepidemiology University of Bordeaux

Award	Attendance	Study	Duration	Start	Domestic fees	International fees
Master	On-Campus	Full-time	find out	September	€7000 year per	€7000 year per

Course fee notes

The tuition fees only change according to full-time professional or student status but do not vary according to location (professionals: 12,000€/year and students: 7,000€/year). No additional costs and no mobility required.

Course overview

The aim of the Eu2P Master in Pharmacovigilance and Pharmacoepidemiology is to respond to the growing need for well-trained professionals in pharmacovigilance and pharmacoepidemiology highlighted by industry, regulatory and academic bodies. There is a particular need for skilled people, trained in medicine risk-benefit assessment, risk management plan elaboration, risk minimization and risk communication.

Eu2P-trained professionals are qualified for new job profiles such as project managers, pharmacoepidemiological coordinators, risk-benefit analysts and people able to interact with statisticians and clinicians. Eu2P is designed for: non-specialists, graduate and postgraduate students in Health and Life Sciences, healthcare professionals, companies, regulatory agencies and academic institutions.

The Eu2P Master offers six high level curricula track specializations to meet specific professional needs in: benefit assessment of medicine, medicine risk identification and quantification, medicine benefit-risk assessment, medicine and public health, medicine risk communication along with an “A la carte” track.